COVID-19 erased the regulatory and trial-related hurdles that Moderna could never surmount before. Yet, how did Moderna know that COVID-19 would create those conditions months before anyone else, and why did they later claim that their vaccine being tested in NIH trials was different than their commercial candidate?
Before COVID-19, Moderna was in danger of hemorrhaging investors, as persistent safety concerns and other doubts about its mRNA delivery system threatened its entire product pipeline. Fear caused by the pandemic crisis made those concerns largely evaporate, even though there is no proof that they were ever resolved.
Silicon Valley’s most influential companies, alongside healthcare companies, US intelligence contractors and the Commons Project Foundation, recently launched the Vaccination Credential Initiative. The initiative’s ambitions reach far beyond vaccines and will have major implications for civil liberties.
Official government guidance has been released in the United Kingdom to assist healthcare professionals in administering the Pfizer/BioNTech vaccine BNT162b2. While the UK government goes to war against supposed misinformation, the official narrative is clearly based on very little to no supporting data from incomplete clinical trials. This article examines the document "Reg 174 Information for UK Healthcare Professionals" and narratives being pushed in the mainstream media that directly contradict that document.
The developers of the Oxford-AstraZeneca vaccine have previously undisclosed ties to the re-named British Eugenics Society as well as other Eugenics-linked institutions like the Wellcome Trust.
$6 billion in Covid-19 vaccine contracts awarded by Operation Warp Speed have been doled out by a secretive government contractor with deep ties to the CIA and DHS, escaping regulatory scrutiny and beyond the reach of FOIA requests.
Researchers at a BSL-3 lab tied to the organizers of the 2001 Dark Winter simulation, DARPA, and the post-9/11 biodefense industrial complex are genetically modifying anthrax to express Covid-19 components, according to FOIA documents.
A Killer Enterprise: How One of Big Pharma’s Most Corrupt Companies Plans to Corner the Covid-19 Cure Market
One of the most politically-connected yet scandal ridden vaccine companies in the United States, with troubling ties to the 2001 anthrax attacks and opioid crisis, is set to profit handsomely from the current Coronavirus crisis.